Eléments de l'association

	Marco Onofrj	2
	Parkinson's disease	1301
	Marco Onofrj *Sauf* Parkinson's disease"	0
	Parkinson's disease *Sauf* Marco Onofrj"	1299
	Marco Onofrj Et Parkinson's disease	2
	Marco Onofrj Ou Parkinson's disease	1301
	*Corpus*	4598

List of bibliographic references

Number of relevant bibliographic references: 2.

Ident.	Authors (with country if any)	Title
000373	Lucilla Parnetti [Italie] ; Davide Chiasserini [Italie] ; Gianni Bellomo [Italie] ; David Giannandrea [Italie] ; Claudia De Carlo [Italie] ; Mohamed M. Qureshi [Émirats arabes unis] ; Mustafa T. Ardah [Émirats arabes unis] ; Shiji Varghese [Émirats arabes unis] ; Laura Bonanni [Italie] ; Barbara Borroni [Italie] ; Nicola Tambasco [Italie] ; Paolo Eusebi [Italie] ; Aroldo Rossi [Italie] ; Marco Onofrj [Italie] ; Alessandro Padovani [Italie] ; Paolo Calabresi [Italie] ; Omar El-Agnaf [Émirats arabes unis]	Cerebrospinal fluid Tau/α‐synuclein ratio in Parkinson's disease and degenerative dementias
000549	Karla Eggert [Allemagne] ; David Squillacote [États-Unis] ; Paolo Barone [Italie] ; Richard Dodel [Allemagne] ; Regina Katzenschlager [Autriche] ; Murat Emre [Turquie] ; Andrew Lees (neurologue) [Royaume-Uni] ; Olivier Rascol [France] ; Werner Poewe [Autriche] ; Eduardo Tolosa [Espagne] ; Claudia Trenkwalder [Allemagne] ; Marco Onofrj [Italie] ; Fabrizio Stocchi [Italie] ; Giuseppe Nappi [Italie] ; Vladimir Kostic [Serbie] ; Jagoda Potic [Serbie] ; Evzen Ruzicka [République tchèque] ; Wolfgang Oertel [Allemagne]	Safety and efficacy of perampanel in advanced Parkinson's disease: A randomized, placebo‐controlled study

Wicri

This area was generated with Dilib version V0.6.23.
Data generation: Sun Jul 3 18:06:51 2016. Site generation: Wed Mar 6 18:46:03 2024